Alphatec Holdings, Inc.

NASDAQ:ATEC

Medical - Devices

Healthcare
$7.06 +3.97%

+$0.33 today

Market cap
$1.10B
Beta
0.87
P/E (TTM)
-10.5
EPS (TTM)
-$0.81
52W Low $6.82High $23.29

Volume 2.80M

Average 3.21M

ATEC EBITDA Margin

EBITDA as a percentage of revenue.

Alphatec Holdings, Inc.NASDAQ: ATEC

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to -0.9%

EBITDA Margin was -0.9% in Q1 FY2026, up 12.7 pp from a year earlier. On a trailing-twelve-month basis it was -0.2%, up 8.0 pp year over year. Over 3 fiscal years it widened by 24.0 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 10 analysts of 20.1% for the fiscal year ending Dec 2026, up from -5.2% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-0.9%-2.7 pp QoQ
Last fiscal yearDec 2025
-5.2%+3.6 pp YoY
LTMMar 2026
-0.2%+8.0 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+12.7 pp+26.2 pp+13.5 pp
1 year+3.6 pp+25.3 pp+21.7 pp
3 years+24.0 pp+33.5 pp+9.5 pp
5 years+40.4 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-5.2%
Year-over-year change
+3.6pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How ATEC compares with its peers on the latest reported figures

  • ATEC's LTM Mar 2026 EBITDA Margin of -0.2% is the 6th highest of the 7 companies compared; the peer median is 16.6%.
  • Its year-over-year change of +8.0 pp is the 3rd highest of 7, against a peer median of +6.2 pp.
  • Over three fiscal years its change of +24.0 pp compares with a peer median of +0.0 pp.
ATEC Competitors Peer median
EBITDA Margin for ATEC and competitors
Company Period LTM level YoY 3-year change
GMEDGlobus Medical, Inc.LTM Jun 202630.1% +6.5 pp+0.4 pp
SYKStryker CorporationLTM Jun 202625.9% +5.9 pp+3.4 pp
SNNSmith & Nephew plcFY202521.7% -1.3 pp-0.4 pp
OFIXOrthofix Medical Inc.LTM Mar 202611.5% +13.4 pp-6.1 pp
XTNTXtant Medical Holdings, Inc.LTM Mar 20269.7% +12.3 pp+21.2 pp
ATECAlphatec Holdings, Inc.LTM Mar 2026-0.2% +8.0 pp+24.0 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026-17.6% -28.7 pp-44.6 pp
Peer median (excluding ATEC) 16.6%+6.2 pp+0.0 pp

Competitors are the stored peer set for ATEC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue243.21M350.87M482.26M611.56M764.16M
Cost of Revenue85.45M117.81M172.06M187.3M232.27M
Gross Profit157.76M233.06M310.2M424.26M531.89M
Gross Margin64.9%66.4%64.3%69.4%69.6%
Research & Development32.02M44.03M70.12M80.72M76.27M
Selling, General & Admin229.27M300.01M374.08M450.2M498.53M
Operating Expenses285.82M380.03M483.6M560.43M614.02M
Depreciation & Amortization30.17M43.93M59.68M83.32M82.56M
EBITDA(106.88M)(102.58M)(110.59M)(53.87M)(39.7M)
EBITDA Margin-43.9%-29.2%-22.9%-8.8%-5.2%
Operating Income(128.06M)(146.98M)(173.4M)(136.17M)(82.13M)
Operating Margin-52.7%-41.9%-36.0%-22.3%-10.7%
Interest Income00000
Interest Expense7.11M5.51M16.64M24.88M21.14M
Other Income / Expenses(16.11M)(5.03M)(13.52M)(25.9M)(61.28M)
Income Before Tax(144.16M)(152.01M)(186.92M)(162.07M)(143.4M)
Pre-Tax Margin-59.3%-43.3%-38.8%-26.5%-18.8%
Income Tax Expense(1.13M)(716K)(277K)50K(45K)
Net Income(143.03M)(151.29M)(186.64M)(162.12M)(143.36M)
Net Margin-58.8%-43.1%-38.7%-26.5%-18.8%
EPS (Basic)(1.50)(1.47)(1.54)(1.13)(0.96)
EPS (Diluted)(1.50)(1.47)(1.54)(1.13)(0.96)
Weighted Avg Shares96.2M103.37M121.24M142.95M150.06M
Weighted Avg Shares (Diluted)96.2M103.37M121.24M142.95M150.06M

Alphatec Holdings, Inc.

NASDAQ:ATEC

Intrinsic Alpha fair value

Locked

Current Price

$7.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.